600 related articles for article (PubMed ID: 36047183)
41. Rhino-Orbital Mucormycosis in a COVID-19 Patient: A Dreadful Challenge.
Dhakal A; Pokharel M; Madhup S; Khadka L; Sapkota B
Kathmandu Univ Med J (KUMJ); 2022; 20(78):249-251. PubMed ID: 37017177
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathological association of mucormycosis in COVID 19 pandemic.
Varshney M; Saxena A; Binnani N; Kumar V; Vyas SP
Indian J Pathol Microbiol; 2023; 66(1):101-105. PubMed ID: 36656219
[TBL] [Abstract][Full Text] [Related]
43. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis.
Yadav S; Bs N; Ak S
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423
[TBL] [Abstract][Full Text] [Related]
44. Invasive Fungal Sinusitis in Post COVID-19 Patients: A New Clinical Entity.
El-Kholy NA; El-Fattah AMA; Khafagy YW
Laryngoscope; 2021 Dec; 131(12):2652-2658. PubMed ID: 34009676
[TBL] [Abstract][Full Text] [Related]
45. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management.
Rudrabhatla PK; Reghukumar A; Thomas SV
Acta Neurol Belg; 2022 Apr; 122(2):273-280. PubMed ID: 34820787
[TBL] [Abstract][Full Text] [Related]
46. Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19.
Munhoz SD; Lellis RF; Reis APC; Del Negro GMB; Sousa MGT; Veasey JV
An Bras Dermatol; 2022; 97(4):501-504. PubMed ID: 35691738
[TBL] [Abstract][Full Text] [Related]
47. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
[TBL] [Abstract][Full Text] [Related]
48. [Coinfection of rhinocerebral mucormycosis and sinus aspergillosis].
Torres-Damas W; Yumpo-Cárdenas D; Mota-Anaya E
Rev Peru Med Exp Salud Publica; 2015 Oct; 32(4):813-7. PubMed ID: 26732934
[TBL] [Abstract][Full Text] [Related]
49. Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
Watanabe A; So M; Mitaka H; Ishisaka Y; Takagi H; Inokuchi R; Iwagami M; Kuno T
Mycopathologia; 2022 Jun; 187(2-3):271-289. PubMed ID: 35312945
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for mortality in patients with pulmonary mucormycosis.
Son HJ; Song JS; Choi S; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
Mycoses; 2020 Jul; 63(7):729-736. PubMed ID: 32304253
[TBL] [Abstract][Full Text] [Related]
51. Utility of in-house and commercial PCR assay in diagnosis of Covid-19 associated mucormycoss in an emergency setting in a tertiary care center.
Pandey M; Sachdev J; Yadav RK; Sharad N; Kanodia A; Biswas J; Janani RS; Gupta S; Singh G; Ekka M; Rana B; Gourav S; Thakar A; Biswas A; Sikka K; Mathur P; Pushker N; Jyotsna VP; Kumar R; Soneja M; Wig N; Srivastava MVP; Xess I
J Med Microbiol; 2023 Aug; 72(8):. PubMed ID: 37624041
[No Abstract] [Full Text] [Related]
52. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.
Pakdel F; Ahmadikia K; Salehi M; Tabari A; Jafari R; Mehrparvar G; Rezaie Y; Rajaeih S; Alijani N; Barac A; Abdollahi A; Khodavaisy S
Mycoses; 2021 Oct; 64(10):1238-1252. PubMed ID: 34096653
[TBL] [Abstract][Full Text] [Related]
53. COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review.
Balushi AA; Ajmi AA; Sinani QA; Menon V; Berieki ZA; Shezawi AA; Azri SA; Rashdi AA; Jardani AA; Baluki TA; Ghaithi SA; Reesi AA; Al-Za'abi AT; Al' Balushi MA; Maqbali TA
Int J Infect Dis; 2022 Aug; 121():203-210. PubMed ID: 35533833
[TBL] [Abstract][Full Text] [Related]
54. COVID-associated rhinocerebral mucormycosis: a retrospective analysis of presentation and outcomes.
Moorthy A; Nayak T; Bachalli PS; Tripathi KK; Dutt SN; Kale P; Bhat P; Suresh PK; Gaikwad R; Raju A; Krishna S; Conjeevaram A; Mehta S; Anil-Kumar A; Haldipur D
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):713-721. PubMed ID: 35849188
[TBL] [Abstract][Full Text] [Related]
55. COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India.
Aranjani JM; Manuel A; Abdul Razack HI; Mathew ST
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009921. PubMed ID: 34793455
[TBL] [Abstract][Full Text] [Related]
56. Mucor in a Viral Land: A Tale of Two Pathogens.
Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
[TBL] [Abstract][Full Text] [Related]
57. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review.
Shah NN; Khan Z; Ahad H; Elderdery AY; Alomary MN; Atwah B; Alhindi Z; Alsugoor MH; Elkhalifa AME; Nabi S; Bashir SM; Yaqub T; Rather GA; Ansari MA
J Infect Public Health; 2022 Nov; 15(11):1299-1314. PubMed ID: 36279686
[TBL] [Abstract][Full Text] [Related]
58. Intestinal mucormycosis in a patient with COVID-19: A case report.
Paliwal P; Rahar S; Sharma A; Gupta D; Ahuja A; Chauhan DS
Indian J Pathol Microbiol; 2022; 65(2):475-477. PubMed ID: 35435400
[TBL] [Abstract][Full Text] [Related]
59. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
[TBL] [Abstract][Full Text] [Related]
60. Rhinocerebral Mucormycosis in a COVID-19 Patient from Nepal: A Case Report.
Kumar Gupta S; Jyotsana P; Singh A; Phuyal D; Allam P
JNMA J Nepal Med Assoc; 2021 Jul; 59(239):703-705. PubMed ID: 34508493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
